Howard G. Welgus Arcutis Biotherapeutics, Inc. (ARQT) insider trading activity

Howard G. Welgus is Director of Arcutis Biotherapeutics, Inc.. Currently has a direct ownership of 121,944 shares of ARQT, which is worth approximately $1.92 Million. The most recent transaction as insider was on May 21, 2021, when has been sold 1,612 shares (Common Stock) at a price of $1.13 per share, resulting in proceeds of $1,822. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 122K

19.74% 3M change

28.35% 12M change

Total Value Held $1.92 Million

Howard G. Welgus Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
May 21 2021	BUY Exercise of conversion of derivative security	$1,822 $1.13 p/Share	1,612 Added 0.75%	212,553 Common Stock
May 03 2021	SELL Open market or private sale	$76,648 $34.84 p/Share	2,200 Reduced 1.03%	210,941 Common Stock
May 03 2021	BUY Exercise of conversion of derivative security	$7,238 $3.29 p/Share	2,200 Added 1.02%	213,141 Common Stock
Apr 16 2021	BUY Exercise of conversion of derivative security	$3,478 $1.31 p/Share	2,655 Added 1.24%	210,941 Common Stock
Apr 01 2021	SELL Open market or private sale	$64,900 $29.5 p/Share	2,200 Reduced 1.05%	208,286 Common Stock
Apr 01 2021	BUY Exercise of conversion of derivative security	$7,238 $3.29 p/Share	2,200 Added 1.03%	210,486 Common Stock
Mar 16 2021	BUY Exercise of conversion of derivative security	$3,475 $1.31 p/Share	2,653 Added 1.26%	208,286 Common Stock
Mar 01 2021	SELL Open market or private sale	$76,142 $34.61 p/Share	2,200 Reduced 1.06%	205,633 Common Stock
Mar 01 2021	BUY Exercise of conversion of derivative security	$7,238 $3.29 p/Share	2,200 Added 1.05%	207,833 Common Stock
Feb 16 2021	BUY Exercise of conversion of derivative security	$3,477 $1.31 p/Share	2,654 Added 1.27%	205,633 Common Stock
Feb 04 2021	BUY Exercise of conversion of derivative security	$33,366 $1.68 p/Share	19,861 Added 8.91%	202,979 Common Stock
Feb 01 2021	SELL Open market or private sale	$76,428 $34.74 p/Share	2,200 Reduced 1.19%	183,118 Common Stock
Feb 01 2021	BUY Exercise of conversion of derivative security	$3,696 $1.68 p/Share	2,200 Added 1.17%	185,318 Common Stock
Jan 12 2021	BUY Exercise of conversion of derivative security	$709 $0.58 p/Share	1,222 Added 0.66%	183,118 Common Stock
Jan 04 2021	SELL Open market or private sale	$61,204 $27.82 p/Share	2,200 Reduced 1.2%	181,896 Common Stock
Jan 04 2021	BUY Exercise of conversion of derivative security	$3,696 $1.68 p/Share	2,200 Added 1.18%	184,096 Common Stock
Dec 14 2020	BUY Exercise of conversion of derivative security	$709 $0.58 p/Share	1,222 Added 0.67%	181,896 Common Stock
Dec 01 2020	SELL Open market or private sale	$57,816 $26.28 p/Share	2,200 Reduced 1.21%	179,844 Common Stock
Dec 01 2020	BUY Exercise of conversion of derivative security	$3,696 $1.68 p/Share	2,200 Added 1.19%	182,044 Common Stock
Nov 12 2020	BUY Exercise of conversion of derivative security	$709 $0.58 p/Share	1,222 Added 0.67%	179,844 Common Stock
Nov 02 2020	SELL Open market or private sale	$40,194 $18.27 p/Share	2,200 Reduced 1.22%	178,622 Common Stock
Nov 02 2020	BUY Exercise of conversion of derivative security	$3,696 $1.68 p/Share	2,200 Added 1.2%	180,822 Common Stock
Oct 15 2020	BUY Exercise of conversion of derivative security	$709 $0.58 p/Share	1,222 Added 0.68%	178,622 Common Stock
Oct 01 2020	SELL Open market or private sale	$58,696 $26.68 p/Share	2,200 Reduced 1.22%	177,400 Common Stock
Oct 01 2020	BUY Exercise of conversion of derivative security	$3,696 $1.68 p/Share	2,200 Added 1.22%	177,790 Common Stock

HGW

Howard G. Welgus

Director

Westlake Village, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ARQT shares.

Notify only if

Value

Insider Trading

Get notified when an Arcutis Biotherapeutics, Inc. insider buys or sells ARQT shares.

Notify only if

Operation

Value

Type

News

Receive news related to Arcutis Biotherapeutics, Inc.

Track Activities on ARQT

Account